glutathione synthetase antibody (JB95-33) Tested Reactivity Anti-Glutathione Synthetase antibody [EPR6563] (ab133592)

The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary

focus on expression areas like forehead & around the Glow in a bottle

Selenium: Another potent antioxidant, selenium works in tandem with glutathione to combat oxidative stress and support the immune system

121 XieH.ZhouF.LiuL.ZhuG.LiQ.LiC.et al (2016)